Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
- 8 November 1994
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 91 (23) , 11202-11206
- https://doi.org/10.1073/pnas.91.23.11202
Abstract
Selective inhibition of the inducible isoform of prostaglandin G/H synthase (cyclooxygenase-2; COX2; EC 1.14.99.1) can be achieved with compounds of the general form of aryl methyl sulfonyls and aryl methyl sulfonamides. DuP 697 and NS-398 are representative examples of these compounds. Both inhibit the constitute (COX1) and inducible (COX2) isoforms of the enzyme with equal potency shortly after mixing, but their potencies increase with time for COX2 selectively. This time-dependent inhibition follows first-order kinetics, and the rate constant for inactivation of COX2 is dose dependent for both compounds. Kinetic analysis allows us to determine KI and kinact (the maximal rate of inactivation) for each inhibitor. The potency of both compounds is substrate concentration dependent, as expected for time-dependent competitive inhibitors. COX2 that has been incubated with these inhibitors, and then extensively dialyzed against buffer, shows no recovery of enzyme activity, while complete recovery of activity is seen for COX1. Thus, these inhibitors irreversibly inactivate COX2 with time, while showing minimal reversible inhibition of COX1. We isolated these inhibitors after long incubation with excess enzyme and subsequent denaturation of the enzyme. Both inhibitors showed no loss of potency resulting from interactions with COX2, suggesting that inhibition is not mediated by covalent modification of the enzyme. These data suggest that binding of these inhibitors to COX2 induces a slow structural transition of the enzyme that results in its selective inactivation.Keywords
This publication has 17 references indexed in Scilit:
- cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.Proceedings of the National Academy of Sciences, 1992
- ANTIINFLAMMATORY AND SAFETY PROFILE OF DUP-697, A NOVEL ORALLY EFFECTIVE PROSTAGLANDIN SYNTHESIS INHIBITOR1990
- Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells.Journal of Biological Chemistry, 1990
- Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzymeBiochemical and Biophysical Research Communications, 1989
- Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.Proceedings of the National Academy of Sciences, 1988
- Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents.Journal of Biological Chemistry, 1985
- Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifierBiochemistry, 1982
- Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosaNature, 1980
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- Esters of Methanesulfonic Acid as Irreversible Inhibitors of AcetylcholinesteraseJournal of Biological Chemistry, 1962